United States Drug Enforcement Administration

SAN ANTONIO – IMC Pro International Inc. has agreed to pay $400,000 to the United States to resolve allegations it violated the Controlled Substances Act through transshipping fentanyl precursor chemicals.

The United States alleged IMC Pro International Inc., a North Carolina-based shipping and logistics company, entered business agreements with several companies operating in China. Under the terms of these arrangements, IMC Pro agreed to provide these Chinese companies with access to IMC Pro’s accounts for common carriers in order to generate domestic shipping labels for the final destinations of various goods and products sold or manufactured by the Chinese companies. These labels identified IMC Pro as the company or entity shipping the packages, though IMC Pro did not store or handle the packages at any time, nor did IMC Pro maintain any records concerning the contents of the packages.

The United States became aware of these business agreements after the U.S. Drug Enforcement Administration seized five packages in Eagle Pass, identifying IMC Pro as the shipper. Chemical analysis determined the five packages contained a total of 26.4 kgs of 1-BOC-4 Piperidone, a List I Regulated Chemical; and 138.66 kgs of (2-Bromoethyl) benzene, a chemical on the DEA’s Special Surveillance List and a laboratory supply within the definition provided under 21 U.S.C § 842(a)(11). Both chemicals are known to be used in the production of fentanyl. The United States alleged its investigation determined these packages were imported into the United States from China, transshipped to Eagle Pass, and intended for transport across the U.S./Mexican border where they were to be sent to be used in the production and manufacture of illicit fentanyl. 

“In addition to going after the drug cartels, DEA will continue to hold companies accountable who make it easy for drug trafficking organizations to get their hands on precursor chemicals to produce deadly synthetic drugs like fentanyl,” said Special Agent in Charge Daniel Comeaux for the DEA Houston Division. “This first-of-its-kind settlement exposes loopholes some companies are exploiting to bring poison to our communities.”

“In the face of the fentanyl epidemic, my office will hold both those who distribute illicit fentanyl and those who provide the means to manufacture such substances accountable for their actions,” said Acting U.S. Attorney Margaret Leachman for the Western District of Texas. “IMC Pro took on a responsibility to ensure the packages shipped under its name complied with federal laws and regulations. I encourage shipping and logistics companies that may have engaged in similar business arrangements to uphold their own responsibilities and assist in the efforts to stop the flow of fentanyl.”

The settlement includes an affirmation by IMC Pro that it will not engage in similar business agreements with foreign-based entities at any time now or in the future; the affirmation is binding on the company’s successors in interest as well. IMC Pro, upon being made aware its domestic shipping accounts had been used to transship fentanyl precursors, immediately took steps to shut down such shipping accounts and end the prior business agreements. IMC Pro is further cooperating with the United States to assist in identifying other instances of transshipment of fentanyl precursors.

Assistant U.S. Attorney Erin Van De Walle negotiated the settlement on behalf of the United States.

The claims resolved by the settlement are allegations only and there has been no determination of liability.